Clinical TrialsSearch results
Number of results: 737
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Study to assess long-term safety in patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment
- CML, Ph+ ALL
- Yamauchi Kyosuke
- 2024-07-05
Not yet recruiting
- The efficacy of IDEC-C2B8 treatment for early-stage pediatric nephrotic syndrome
- Childhood-onset idiopathic nephrotic syndrome
- Yamamura Tomohiko
- 2024-08-07
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
Recruiting
- Phase III Study of KD-380
- Chronic inflammatory demyelinating polyradiculoneuritis and multifocal motor neuropathy
- Yamamoto Akihiko
- 2024-05-09
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.
- colorectal cancer/ gastric cancer
- Yakult Honsha Co.,Ltd
- 2006-11-01
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29
Other
- randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection
- stage IB-IIIA non small cell lung cancer after complete resection
- West Japan Oncology Group
- 2005-09-06
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26